Skip to content
All Brands

McKesson

1 recall on record · Last recall: Jun 10, 2026

Read the history in context

Records, not a safety rating.

Recall counts do not account for sales volume, exposure or differences in reporting. Agency records can overlap. A low count does not establish that a brand or product is safe.

View source coverage →

Severity Breakdown

Class I — Serious
0
Class II — Moderate
1
Class III — Low Risk
0

Categories

MEDICATION

Recall Timeline

Class IIFDAJun 10, 2026

McKesson — Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.

Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01 Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.

Track McKesson recalls automatically

Get an alert when a matching McKesson recall turns up.

Start Free Trial